Major interaction on record — check this product against your medications before combining. Based on 4 of 8 ingredients. Check your meds →
Dietary supplement

AminO.D. Strawberry Limeade Ingredients & Drug Interactions

by Purus Labs

Powder Category: Amino Acid/protein
Most serious interaction: Major
The interaction bottom line Most serious interaction: Major

AminO.D. Strawberry Limeade is a dietary supplement by Purus Labs with 8 active ingredients. Its ingredients are commonly taken for depression and mood, skin condition vitiligo, pain conditions.Based on those ingredients, 20 medications have a known interaction with it, the most serious rated major. The ingredients most likely to interact are L-Phenylalanine, L-Threonine, L-Lysine. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of AminO.D. Strawberry Limeade by Purus Labs

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Partial disclosure
Ingredient Transparency · database check
Partial

Most active ingredients list an amount, but at least one is hidden in a blend or missing.

Why this rating?
  • The label discloses an exact amount for 7 of its 8 active ingredients.
  • “AminOD EAA Repletion Matrix” is a proprietary blend — the label gives one combined amount (5.80 Gram(s)) without saying how much of each component you get.

AminO.D. contains 8 ingredients total, including the amino acids L-Leucine, L-Isoleucine, L-Phenylalanine, L-Valine, L-Histidine, L-Threonine, and L-Lysine, plus proprietary blends called AminoBlast and AminOD EAA Repletion Matrix. These are branched-chain and essential amino acids designed to support muscle protein.

The inactive ingredients are malic acid, natural and artificial flavor, citric acid, silica, and sucralose.

Does it work?

Insufficient evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Insufficient

There isn't enough reliable clinical evidence to rate this product's ingredients for its stated purpose.

Why this rating?
  • The label markets this product for: muscle protein synthesis and athletic performance.
  • We looked for evidence on: Athletic performance, Muscle strength, muscle recovery, protein synthesis, exercise performance.
  • The closest evidence on file: Lysine is rated "Insufficient Reliable Evidence To Rate" for Athletic performance (Natural Medicines).
  • Also on file: Lysine is rated "Insufficient Reliable Evidence To Rate" for Muscle strength.

The amino acids in this product have varying levels of evidence. L-Phenylalanine is possibly effective for vitiligo (a pigmentation condition) but possibly ineffective for ADHD, with insufficient evidence for alcohol use disorder or multiple sclerosis.

L-Lysine is possibly effective for cold sores. L-Histidine and L-Threonine have insufficient evidence for the conditions studied — eczema, kidney failure, rheumatoid arthritis, ALS, and multiple sclerosis — so their effectiveness is not established in our data.

The evidence for this product's amino acid blend as a whole is not addressed in the data we hold.

The evidence, ingredient by ingredient Phenylalanine Histidine Threonine Lysine

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 3 of the 4 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 4 of 4.
  • General safety write-ups exist for 4 of 4.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

L-Phenylalanine is generally well tolerated at typical doses but should not be used by people with phenylketonuria (PKU). Reported side effects include anxiety, constipation, headache, heartburn, insomnia, nausea, and sedation.

L-Threonine may cause headache and minor gastrointestinal upset including diarrhea, flatus, or constipation. L-Lysine is generally well tolerated but may cause abdominal pain, diarrhea, or indigestion, especially at high doses; long-term safety is not well studied.

L-Histidine safety at supplement doses is not well established, and L-Leucine, L-Isoleucine, and L-Valine safety data is not on file. For pregnancy and breastfeeding, L-Phenylalanine supplements should be avoided — safety has not been established — though dietary amounts are likely safe.

L-Histidine is likely safe in pregnancy and lactation. For L-Threonine and L-Lysine, supplement safety during pregnancy and breastfeeding has not been well studied, so check with your clinician first.

Side effects, ingredient by ingredient Phenylalanine Histidine Threonine Lysine

Meds to double-check

Major interaction found
Known Interaction Concern · database check
Major identified

At least one ingredient has a documented Major-severity interaction. Check your medications for a personalized result.

Why this rating?
  • 3 of the 4 matched ingredients can interact with medications — Lysine, Phenylalanine, Threonine.
  • The most serious interaction on file is rated Major.
  • Some involve high-stakes drug classes: Parkinson's medications.
  • For scale: 20 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Check with your pharmacist if you take levodopa (a Parkinson's medication), baclofen (a muscle relaxer), MAOIs (older antidepressants), NMDA antagonists (such as dextromethorphan or memantine), or 5-HT4 agonists (certain digestive medications). These are the drug types with documented interactions in this product.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glancePartially disclosed formula with insufficient evidence for its stated purpose. Major medication interactions have been identified, and safety information is well characterized.

This product is a branched-chain and essential amino acid blend meant for muscle support, but it's not right for everyone. If you take levodopa, baclofen, MAOIs, NMDA antagonists, or 5-HT4 agonists, check with your pharmacist before starting — the interactions are real.

Pregnant or breastfeeding people should talk to their doctor about L-Phenylalanine use. Anyone with PKU should avoid this product.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 4 of 8 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Jan 25, 2017.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about AminO.D. Strawberry Limeade, straight from the product label.

Brand Purus Labs
Barcode (UPC) 855734002277
Net contents 300 Gram(s); 10.6 Oz(s)
Market status On market
Date entered into DSLD Jan 25, 2017
DSLD ID 67409
Product type Amino Acid/protein
Supplement form Powder
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for AminO.D. Strawberry Limeade by Purus Labs, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
7.5 Gram(s)
Maximum serving Sizes:
7.5 Gram(s)
Servings per container
40
UPC/BARCODE
855734002277
IngredientAmount% DV
L-Leucine2.1 Gram(s)--
L-Isoleucine480 mg--
L-Phenylalanine839 mg--
L-Valine600 mg--
L-Histidine480 mg--
L-Threonine600 mg--
L-Lysine719 mg--
AminoBlast0 NP--
AminOD EAA Repletion Matrix5.8 Gram(s)--

Other ingredients: Malic Acid, Natural and Artificial flavor, Citric Acid, Silica, Sucralose

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

NUTRITIONAL INFO

PROUDLY MADE IN THE U.S.A.

SUBSTANTIATED EFFECTS The importance of amino acids, with regards to muscle protein synthesis, has long been accepted and validated; however, which exact amino acids at what specific ratios are the more important questions.

It even outperforms whole protein!

36 PERCENT AMINOBLAST L-LEUCINE 14 PERCENT L-PHENYLALANINE 12 PERCENT L-LYSINE 10 PERCENT L-VALINE 10 PERCENT L-THREONINE 8.5 PERCENT L-ISOLEUCINE 8.5 PERCENT L-HISTIDINE

ESSENTIAL AMINO ACID REPLETION DRINK PRE - INTRA - POST MPS ENHANCER

40 TRUE SERVINGS

NATURAL & ARTIFICIAL FLAVOR

MORE EFFECTIVE THAN PROTEIN LESS EXPENSIVE THAN PROTEIN FEWER CALORIES THAN PROTEIN

Suggested/Recommended/Usage/Directions

SIMPLIFIED USAGE 1 LEVEL SCOOP 8 OZ. WATER OR OTHER DRINK ALL DAY ANY DAY

AminOD usage: As research provides evidence for effectively taking a serving of AminOD pre, intra and 1-2 hours post workout, mix one serving in 8 oz. cold water in any of the above instances to maximize muscle protein synthesis. For an anytime flavor splash, mix one serving in your water and enjoy as needed.

Brand IP Statement(s)

We conducted a meta analysis on over 10 years of ergogenic amino acid research to bring you the most comprehensively anabolic amino acid composition available, AminOD, the industry's first muscle protein synthesis-stimulating essential amino acid matrix.

Precautions

WARNING: AminOD is intended only for healthy adults over the age of 18.

Do not use if you are currently pregnant or nursing, could be pregnant, or are attempting to become pregnant.

Consult a licensed healthcare practitioner before using this product. Discontinue use and contact a doctor immediately if you experience an irregular or rapid heart beat, chest pain, shortness of breath, dizziness, lightheadedness, fainting or presyncope, tremors, headache, nausea, or other similar symptoms. If you are a performance athlete, please check with your sanctioning body prior to use to ensure compliance. PHENYLKETONURICS: Contains phenyllalanine

Formula

PHENYLKETONURICS: Contains phenyllalanine

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Formulation

LACTOSE & DYE FREE

FDA Statement of Identity

DIETARY SUPPLEMENT WITH SEVEN ESSENTIAL AMINO ACIDS

See for yourself

AminO.D. Strawberry Limeade by Purus Labs label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in AminO.D. Strawberry Limeade by Purus Labs

These are the 8 active ingredients this product is made of. Select any to open its full monograph.

Serving size7.5 Gram(s) Dosage formPowder Servings per container40 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

AminOD EAA Repletion Matrix

5.8 Gram(s) per serving

Other (inactive) ingredients: Malic Acid, Natural and Artificial flavor, Citric Acid, Silica, Sucralose. These complete the product’s ingredient list but are not active constituents.

Interaction report

AminO.D. Strawberry Limeade by Purus Labs Drug Interactions

Want to check YOUR meds against AminO.D. Strawberry Limeade?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
20Drugs
8 Major 11 Moderate 1 Minor

Ingredients driving the most interactions

Each ingredient & the kinds of drugs it affects

For each ingredient in AminO.D. Strawberry Limeade with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

L-Phenylalanine3 drug types · 16 drugs

Levodopa

Phenylalanine, especially in high doses, can reduce the effectiveness of levodopa.
Phenylalanine competes with levodopa for carrier-mediated transport into the brain. The resulting reduction in levels of levodopa in the brain can exacerbate tremor, rigidity, and the "on-off" phenomenon in patients with Parkinson disease.

Likelihood Probable Evidence B
Baclofen

Concomitant intake of phenylalanine may reduce the intestinal absorption of baclofen.
Phenylalanine and baclofen share the same intestinal carrier for absorption; phenylalanine competitively inhibits the absorption of baclofen, reducing its plasma levels.

Likelihood Possible Evidence D
Monoamine Oxidase Inhibitors (Maois)

Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
L-phenylalanine is metabolized to tyrosine. Some evidence suggests that L-phenylalanine, given with the non-selective MAOI pargyline, might prevent the elimination of tyramine, increasing the risk of hypertensive crisis. However, this was not reported in a small number of patients when using L-phenylalanine with the partially selective MAO-B inhibitor, selegiline.

Likelihood Possible Evidence D

L-Threonine1 drug type · 3 drugs

Nmda Antagonists

Theoretically, threonine might decrease the effects of NMDA antagonists.
Threonine increases central nervous system (CNS) glycine levels. Glycine seems to bind a site on NMDA receptors and enhance the activity of the receptors.

Likelihood Likely Evidence B

L-Lysine1 drug type · 1 drug

5-Ht4 Agonists

Theoretically, lysine may reduce the effects of 5-HT4 agonists.
Animal research suggests that L-lysine is a partial serotonin receptor 4 (5-HT4) antagonist and inhibits diarrhea induced by the 5-HT4 agonist, 5-hydroxytryptophane.

Likelihood Unlikely Evidence D
The maker

Brand information

Manufacturer and brand details for AminO.D. Strawberry Limeade, from the product label.

Purus Labs

See all Purus Labs products
Name
Purus Labs
Street Address
11370 Pagemill Rd.
City
Dallas
State
TX
ZipCode
75243
Phone Number
855.629.6328
Web Address
puruslabs.net
Pharmacist Counseling Corner

AminO.D. Strawberry Limeade by Purus Labs: Common Questions

Does AminO.D. Strawberry Limeade by Purus Labs interact with any medications?
Yes. Based on its ingredients, AminO.D. Strawberry Limeade has a known interaction with 20 medications, including 8 rated major. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
AminO.D. Strawberry Limeade contains 8 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Can I use this if I have PKU?
No. L-Phenylalanine in this product is not safe for people with phenylketonuria (PKU) because your body cannot process phenylalanine properly. Talk to your doctor or pharmacist about alternatives.
Is it safe to take while pregnant?
L-Phenylalanine supplements should be avoided during pregnancy because safety has not been established. The other amino acids in this product have not been well studied in pregnancy either. Talk to your clinician before starting.
What side effects might I notice?
The most common reported side effects are anxiety, headache, insomnia, nausea, constipation, and heartburn. Some people also report diarrhea, abdominal pain, or indigestion. Most side effects are mild, but stop and talk to your pharmacist if they bother you or don't improve.
What is this product supposed to do?
AminO.D. is a branched-chain and essential amino acid formula designed to support muscle protein. It's often used by people looking to enhance workout recovery or muscle maintenance, but the evidence for this specific blend is not in the data we hold.
Does L-Lysine in this product actually work for cold sores?
L-Lysine is possibly effective for cold sores based on available evidence. However, the dose and formulation in this product, combined with the other amino acids, may differ from what was studied, so results can vary.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if AminO.D. Strawberry Limeade is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

AminO.D. Strawberry Limeade label
Sources

Sources & How We Checked

AminO.D. Strawberry Limeade's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 37 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Phenylalanine 23 references
  1. Rouse B, Azen C, Koch R, et al. Maternal phenylketonuria collaborative Study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae. Am J Med Genet 1997;69:89-95. DOI
  2. Sturtevant FM. Use of aspartame in pregnancy. Int J Fertil 1985;30:85-7.
  3. Silkaitis RP, Mosnaim AD. Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brain. Brain Res 1976;114:105-15.
  4. Lehmann WD, Theobald N, Fischer R, Heinrich HC. Stereospecificity of phenylalanine plasma kinetics and hydroxylation in man following oral application of a stable isotope-labelled pseudo-racemic mixture of L- and D-phenylalanine. Clin Chim Acta 1983;128 PubMed
  5. Mosnik DM, Spring B, Rogers K, Baruah S. Tardive dyskinesia exacerbated after ingestion of phenylalanine by schizophrenic patients. Neuropsychopharmacology 1997;16:136-46. PubMed
  6. Siddiqui AH, Stolk LM, Bhaggoe R, et al. L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology 1994;88:215-8. PubMed
  7. Birkmayer W, Riederer P, Linauer W, Knoll J. L-deprenyl plus L-phenylalanine in the treatment of depression. J Neural Transm 1984;59:81-7. PubMed
  8. Nutt JG, Woodward WR, Hammerstad JP, et al. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med 1984;310:483-8. PubMed
  9. Baruzzi A, Contin M, Riva R, et al. Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients. Clin Neuropharmacol 1987;10:527-37. PubMed
  10. Juncos JL, Fabbrini G, Mouradian MM, et al. Dietary influences on the antiparkinsonian response to levodopa. Arch Neurol 1987;44:1003-5. PubMed
  11. Eriksson T, Granerus AK, Linde A, et al. "On-off" phenomenon in Parkinson's disease: relationship between dopa and other large neutral amino acids in plasma. Neurology 1988;38:1245-8. PubMed
  12. Baker GB, Bornstein RA, Rouget AC, et al. Phenylethylaminergic mechanisms in attention-deficit disorder. Biol Psychiatry 1991;29:15-22.. PubMed
  13. Wood DR, Reimherr FW, Wender PH. Treatment of attention deficit disorder with DL-phenylalanine. Psychiatry Res 1985;16:21-6.. PubMed
  14. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: National Academy Press, 2002. Available at: http://www.n
  15. Cederbaum S. Phenylketonuria: an update. Curr Opin Pediatr 2002;14:702-6. PubMed
  16. Cejudo-Ferragud, E., Nacher, A., Polache, A., Cercos-Fortea, T., Merino, M., and Casabo, V. G. Evidence of competitive inhibition for the intestinal absorption of baclofen by phenylalanine. Int J of Pharm (Amsterdam) 1996;132:63-69. DOI
  17. Fischer, E., Heller, B., Nachon, M., and Spatz, H. Therapy of depression by phenylalanine. Preliminary note. Arzneimittelforschung. 1975;25(1):132.
  18. Beckmann, H., Strauss, M. A., and Ludolph, E. Dl-phenylalanine in depressed patients: an open study. J.Neural Transm. 1977;41(2-3):123-134. PubMed
  19. Sabelli, H. C., Fawcett, J., Gusovsky, F., Javaid, J. I., Wynn, P., Edwards, J., Jeffriess, H., and Kravitz, H. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplem
  20. Cotzias, G. C., Van Woert, M. H., and Schiffer, L. M. Aromatic amino acids and modification of parkinsonism. N Engl.J Med 2-16-1967;276(7):374-379. PubMed
  21. Kravitz, H. M., Sabelli, H. C., and Fawcett, J. Dietary supplements of phenylalanine and other amino acid precursors of brain neuroamines in the treatment of depressive disorders. J Am Osteopath.Assoc 1984;84(1 Suppl):119-123. DOI
  22. Mann, J., Peselow, E. D., Snyderman, S., and Gershon, S. D-phenylalanine in endogenous depression. Am.J.Psychiatry 1980;137(12):1611-1612. PubMed
  23. Katoulis AC, Alevizou A, Bozi E, et al. A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines. Clin Exp Dermatol 2010;35(5):473-6. PubMed

See these in context on the Phenylalanine monograph →

Histidine 3 references
  1. Histidine — MedlinePlus (U.S. National Library of Medicine) Source
  2. Amino Acids — MedlinePlus (U.S. National Library of Medicine) Source
  3. Dietary Supplements: What You Need to Know — NIH Office of Dietary Supplements Source

See these in context on the Histidine monograph →

Threonine 4 references
  1. Tandan R, Bromberg MB, Forshew D, et al. A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data. Neurology 1996;47:1220-6. PubMed
  2. Lee A, Patterson V. A double blind study of L-threonine in patients with spinal spasticity. Acta Neurol Scand 1993;88:334-8. PubMed
  3. Blin O, Pouget J, Aubrespy G, et al. A double-blind placebo controlled trial of L-threonine in amyotrophic lateral sclerosis. J Neurol 1992;239:79-81.
  4. Roufs JB. L-threonine as a symptomatic treatment for amyotrophic lateral sclerosis (ALS). Med Hypotheses 1991;34:20-3. PubMed

See these in context on the Threonine monograph →

Lysine 7 references
  1. Thein DJ, Hurt WC. Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis. Oral Surg Oral Med Oral Pathol 1984;58:659-66. PubMed
  2. McCune MA, Perry HO, Muller SA, O'Fallon WM. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis 1984;34:366-73.
  3. DiGiovanna JJ, Blank H. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Arch Dermatol 1984;120:48-51. DOI
  4. Milman N, Scheibel J, Jessen O. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol 1980;60:85-7.
  5. Griffith RS, Walsh DE, Myrmel KH, et al. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica 1987;175:183-90. DOI
  6. Lo JC, Chertow GM, Rennke H, Seifter JL. Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion. Am J Kidney Dis 1996;28:614-7. PubMed
  7. Smriga M, Torii K. L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15370-5.

See these in context on the Lysine monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring